Life Sciences Advanced Technologies, Inc.

LSAT was instrumental in the development of Interferon, as well as, a pioneer in the development of T7 Polymerase and RNase H for Isothermal Amplification Technology, it was one of the first companies to develop Lyophilization technology, and was the very first company in the world to ever manufacture Reverse Transcriptase from Avian Myelblastosis Virus. Since 1980, the Company has largely concentrated its product development on enzymes that have been used in the detection of infectious diseases that include: Influenza, HIV, Dengue Fever, Norovirus, and Zika. The Company’s continued success in the field of molecular biology is a direct outgrowth of its R&D years.